Category M62 represents a grouping of muscle-related conditions that are not classified under primary inflammatory, infectious, or specific genetic dystrophic categories. This category includes clinical entities such as disuse atrophy (muscle wasting), nontraumatic muscle ruptures, contractures, and ischemic muscle infarctions. It is also used to document immobility syndrome and diastasis (separation) of muscle fibers. These disorders may result from prolonged immobilization, neurological deficits, localized vascular compromise, or structural failures of the muscle-tendon unit without external trauma. Clinically, this category is vital for describing the musculoskeletal sequelae of chronic illness, aging, and physical inactivity, providing a framework for identifying functional impairments that often require rehabilitative or surgical intervention.
Distinguish between primary muscle disorders and secondary muscle wasting or atrophy due to disuse or neurological conditions.
Example: Patient presents with persistent muscle wasting and atrophy of the right quadriceps (M62.551) secondary to six months of immobilization following a complex tibial plateau fracture. Physical exam shows a 3cm circumference decrease compared to the left side. Plan includes referral to physical therapy for targeted muscle re-education. Laterality: Right. Episode of care: Chronic management of post-traumatic atrophy.
Billing Focus: Laterality and site specificity (e.g., right vs. left, upper arm vs. thigh).
Explicitly document the clinical significance of muscle weakness and whether it is generalized or localized to specific muscle groups.
Example: 68-year-old female reports generalized muscle weakness (M62.81) for the past three weeks. Strength is 4/5 in all major muscle groups. Gait is slow but stable. Review of medications shows high-dose statin use. Laboratory tests ordered for creatine kinase to rule out myopathy. Severity: Moderate, impacting ADLs.
Billing Focus: Documentation of generalized vs. localized weakness to support M62.81.
When documenting sarcopenia, ensure the clinical criteria such as loss of muscle mass and impaired physical function are clearly stated.
Example: Patient diagnosed with age-related sarcopenia (M62.84). Dual-energy X-ray absorptiometry (DEXA) shows skeletal muscle index below threshold for age and sex. Functional testing demonstrates a grip strength of 18kg and a 4-meter walk speed of 0.7 m/s. Status: Chronic condition with high risk of falls and mobility impairment.
Billing Focus: Specific diagnosis code M62.84 to differentiate from general muscle wasting.
Specify the exact site and depth when documenting muscle contractures to facilitate accurate procedural and diagnostic coding.
Example: Contracture of the left psoas muscle (M62.48) resulting in a 15-degree hip flexion deformity. Patient has significant pain during ambulation. Condition is a complication of chronic spinal stenosis and subsequent postural adjustments. Laterality: Left. Site: Multiple sites (lower limb/pelvis).
Billing Focus: Anatomical specificity and laterality for M62.4 series codes.
For nontraumatic rhabdomyolysis, document the causative agent and any associated organ dysfunction such as acute kidney injury.
Example: Acute rhabdomyolysis (M62.82) identified by serum creatine kinase (CK) levels exceeding 15,000 U/L following an accidental fall and prolonged lay on the floor for 12 hours. Patient also presents with acute kidney injury (N17.9) with elevated creatinine. Management involves aggressive intravenous hydration and metabolic monitoring.
Billing Focus: Documentation of cause (e.g., fall, statin, trauma) and resulting systemic manifestations.
Appropriate for monitoring stable muscle disorders like chronic muscle weakness or sarcopenia.
Used when muscle disorders are complicated by comorbidities or require medication adjustments (e.g., managing statin-induced myopathy).
Typical for an initial specialist consultation for complex undiagnosed muscle weakness or atrophy.
Essential for evaluating muscle weakness (M62.81) and determining if the origin is muscular or nerve-related.
Used to definitively diagnose types of muscle hypertrophy or wasting when imaging is inconclusive.
The standard of care for treating muscle atrophy (M62.5) and sarcopenia (M62.84).
Used to quantify the severity of muscle contractures (M62.4).
Often performed to rule out vascular causes when evaluating nontraumatic compartment syndrome (M62.2).
Required for patients with severe muscle weakness or separation (diastasis) to restore movement patterns.
Primary laboratory test for diagnosing and monitoring rhabdomyolysis (M62.82).